Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Urinary Bladder Neoplasms × Biopsy × Clear all

Phase

Phase 2 5 Phase 3 2 Phase NA 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Melanoma 11 Neoplasm Metastasis 7 Prostatic Neoplasms 6 Triple Negative Breast Neoplasms 5 Multiple Myeloma 5 Lymphoma 5 Lung Neoplasms 5 Leukemia, Myeloid, Acute 4 Lymphoma, Mantle-Cell 3 Leukemia, Myelomonocytic, Chronic 3 Leukemia, Biphenotypic, Acute 3 Hematologic Neoplasms 3 Fallopian Tube Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Burkitt Lymphoma 3 Waldenstrom Macroglobulinemia 2 Uterine Cervical Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Oropharyngeal Neoplasms 2 Lymphoma, Large B-Cell, Diffuse 2 Liposarcoma 2 Glioma 2 Colorectal Neoplasms 2 Carcinoma, Transitional Cell 2 Carcinoma, Renal Cell 2 Carcinoma, Merkel Cell 2

Interventions

Gemcitabine 15 pembrolizumab 14 Cisplatin 12 avelumab 6 Nivolumab 6 Docetaxel 6 enfortumab vedotin 5 atezolizumab 5 sacituzumab govitecan 4 durvalumab 4 Paclitaxel 4 Cystectomy 4 Carboplatin 4 vofatamab 3 tremelimumab 3 Mitomycin 3 vinflunine 2 tisotumab vedotin 2 poly ICLC 2 aldesleukin 2 Radiotherapy 2 Ipilimumab 2 Interleukin-2 2 Immunoglobulin G 2 Cystoscopy 2 Clinical Trials, Phase II as Topic 2 BCG Vaccine 2 B701 protein, Human herpesvirus 6 2 Albumin-Bound Paclitaxel 2 ALT-801 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00556621 2015-07-30

GEMCIRAV

Institut du Cancer de Montpellier - Val d'Aurelle

Phase 1/2 Completed

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡